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Abstract Electrodiagnostic techniques have been utilized
in surgery since the early 1960s. These techniques have
been primarily used in neurosurgery; however, with the
introduction of neuromodulation for voiding dysfunction,
these techniques have now found their way into the field of
female pelvic medicine. This article will review techniques
applicable to evaluate pelvic floor function as it relates to
neuromodulation. It will also review the literature describing
how these techniques are used to help determine appropriate
candidates as well as improve surgical outcomes. A PubMed
search was conducted using the terms neuromodulation,
Interstim, electrodiagnosis, electrodiagnostic techniques, elec-
tromyography with limits to the pelvic floor, and voiding
dysfunction. Eight articles and three abstracts were found that
directly related to the use of electrodiagnostic techniques as
they apply to neuromodulation. Electrodiagnostic techniques
may play a role in helping predict appropriate candidates for
neuromodulation as well as improve surgical outcomes.
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Introduction
Intraoperative electrodiagnostic techniques have been used
since the early 1960s when Larsen et al. introduced the use of
somatosensory evoked potentials (SSEPs) for monitoring
responses during neurosurgical procedures [1]. These techni-
ques were soon adopted by spine surgeons as a supplement
to provide warning of compromised spinal cord function [2].
In addition to SSEPs, numerous neurophysiological monitor-
ing methods exist, including continuous free-running electro-
myography (EMG), evoked EMG, compound muscle action
potentials, rectal and urethral EMG, motor-evoked potential
and most recently, spinal cord mapping.
In performing neuromodulation for pelvic floor dysfunc-
tion, electrodiagnostic techniques may also play a role during
both the lead wire implant phase and in reprogramming the
implantable pulse generator (IPG) in patients with suboptimal
response [3, 4]. This provides more sensitive objective
monitoring that can supplement the gross motor response.
It may also be a more reliable method of determining lead
wire placement when placing at alternate sites such as the
pudendal nerve [5]. Electrodiagnostic techniques may also
play a role in evaluating appropriate candidates for implant.
Definitions
Evoked potentials
Evoked potentials are electrical potentials recorded from the
nervous system following a delivered stimulus.
Somatosensory-evoked potentials
Somatosensory-evoked potentials are elicited by tactile or
electrical stimulation of a sensory or mixed nerve in the
periphery (most commonly the median and posterior tibial
nerves) with a resultant waveform that is picked up in
several areas along the spine and scalp. The waveforms are
described in terms of morphology, latency, and dispersion.
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They are used primarily to reveal or localize a lesion
involving the somatosensory pathways.
Motor-evoked potentials
Motor-evoked potentials are recorded from muscles fol-
lowing direct stimulation of exposed motor cortex or
transcranial stimulation of the motor cortex. Used widely
in brain tumor resection and aneurysm surgery.
Compound muscle action potentials
A compound muscle action potential is a summation of
nearly synchronous muscle fiber action potentials recorded
from a muscle produced by direct or indirect stimulation of
the nerve supplying that muscle. The amplitude, duration
and latency are recorded. An increased latency is reflective
of a neuropraxic (demyelination) injury while a decrease in
amplitude indicates axonal dropout.
Electromyography
Electromyography is the recording of electrical potentials
generated by the depolarization of muscle fibers. Electromy-
ography is typically distinguished as surface or needle EMG.
Surface EMG
Surface EMG is a kinesiologic study that provides qualitative
and quantitative descriptions of a muscle’s activity over a
period of time and thus describes more patterns of behavior.
Surface EMG reflects the total muscle activity and as such
gives information of total functioning mass. Examples of
commonly used studies that employ surface EMG include
anal manometry and urodynamics.
Needle EMG
Needle EMG is the recording and study of individual motor
units (motor unit action potentials) via the insertion of a
needle directly into the muscle being evaluated. A motor
unit is defined as an anterior horn cell, its axon and
branches, and the muscle fibers it innervates. The number
of muscle fibers innervated is known as the innervations
ratio. Motor unit action potentials are the summation of the
potentials recorded from all muscle fibers in the motor unit
within the recording range of the electrode. The advantages
of needle EMG are that it is more precise and sensitive,
provides information concerning denervation, re-innervation,
upper and lower motor neuron function, activity and time
course of the neurologic process, as well as aiding in prognosis.
Neuromodulation and electrodiagnosis
Sacral neuromodulation (SNM) was approved for the
treatment of urge incontinence in 1997 and gained two
further indications for the treatment of urgency/frequency
and non-obstructive urinary retention in 1999. Ideal
placement of the lead wire is guided by the objective
motor response (bellows and/or great toe flexion) and the
subjective sensory report from the patient (typically a
tapping or vibration sensation in the vagina, rectum, and/
or scrotum). The ideal parameter for lead placement has
not been elucidated, but a report by Cohen and colleagues
suggested that a motor response was far superior to a
sensory response [6]. In this study, 95% of those that had
a positive intraoperative motor response went on to have a
successful trial and were implanted vs. 5% that elicited a
sensory response only. This study emphasizes the impor-
tance of achieving an intraoperative motor response.
When evaluating for a motor response, the surgeon relies
on gross motor movements to determine the correct lead
placement; however, this response is often elicited at
much higher stimulation amplitudes than would be
clinically used and may be uncomfortable for the patient.
Additionally, the human eye cannot detect subtle changes
in the amplitude of response. In a small series by Benson
[3], electrodiagnostic techniques were utilized at the time
of implant to fine tune lead wire placement. Compound
muscle action potentials (cMAPs) in the levator ani
muscles and urethra were recorded using a sponge
Fig. 1 a Ring electrode mounted
on a 14-French catheter placed at
the mid-urethra. b Sponge Elec-
trode—placed transvaginally or
transrectally
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electrode placed vaginally or rectally, and a ring electrode
placed on a Foley catheter (Fig. 1a, b). The resulting wave
forms were analyzed with regard to latency and amplitude
(Fig. 2). The advantage of analyzing the motor response
with this technique is that small decrements in response
can be measured electrodiagnostically. These subtle
changes in amplitude cannot be appreciated with the
naked eye when looking for a motor response. Using this
technique, Benson achieved an 80% implant rate, which at
the time of publication, was significantly higher than the
50% response being reported. Since the introduction of the
tined lead, no other study has evaluated the use of
electrodiagnostic techniques on outcomes.
Benson et al. also found that utilizing electrodiagnostic
techniques was a valuable tool for screening appropriate
candidates for implant. Preoperatively, 46 patients underwent
electrodiagnostic evaluation of the pelvic floor, includingmotor
conduction studies of the pudendal nerve (inferior hemorrhoid-
al and perineal branches) as well as sacral reflex testing. The
sacral reflexes included the clitoral–anal reflex (CAR), the
urethral–anal reflex, and the bladder–anal reflex (BAR). Of
those 46 subjects, 15 had urinary retention with the remaining
categorized as urgency/frequency and/or urge incontinence. In
looking for factors predictive of “responders” vs. “non-
responders,” they found in the urgency/frequency group that a
normal CAR latency and an elevated BAR sensory
threshold were associated with improved outcomes. In
both the urge incontinence and retention groups, the
presence of an increased CAR sensory threshold was
predictive of being a responder [7]. Unfortunately, this
data was only published in abstract form and no further
studies have been conducted to confirm these findings. In
a related study, Mutone et al. found a direct relationship
Fig. 2 Evoked potentials generated by the implantable pulse generator and recording in the urethral rhabdosphincter and external anal sphincter.
The urethral leads are inverted in this particular tracing. Note the recordings are obtained from each of the four electrodes
Table 1 Relative contribution of the sacral nerve roots to the urethra,










Urethra S3 (61%) S2 (24%) S4 (15%)
Levator S3 (75%) S4 (19%) S2 (6%)
Anal
sphincter
S2 (45%) S3 (44%) S4 (11%)
Abductor
hallicus
S2 (90%) S3 (8%) S4 (2%)






Fig. 3 Recorded cMAP from the levator ani muscle in patients with
an implanted InterStim system. The first figure demonstrates a very
small stimulus artifact indicating that only a small amount of energy is
required to obtain a motor response. In the second example, the
stimulus artifact is larger indicating a greater amount of energy is
required to get the motor response
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between the relative change in amplitude in the urethral
cMAP and degree of improvement in bladder function in
subjects who underwent repeat testing. There was no
relationship to the absolute amplitude of the urethral or
levator cMAP [8].
Sacral neuromodulation generally involves placement of
the lead through the S3 foramen, but is this the optimal nerve
root? In a small series of three subjects undergoing sacral
neuromodulation test stimulation, each of the nerve roots S2-
S4 were stimulated [9]. The cMAPs were simultaneously
recorded from four sites; the urethral rhabdosphincter via the
ring electrode, the levator ani via the vaginal sponge
electrode, the external anal sphincter via the monopolar
needles, and the abductor hallicus (great toe) via the surface
electrode. The results demonstrated that the innervation of
the urethra and levator was predominantly S3, with only a
small contribution from S4. The S2 and S3 nerve roots
contributed equally to the innervation of the external anal
sphincter (Table 1). These findings suggest that S3 is the
most logical choice from an electrodiagnostic standpoint.
McLennan [4] reported on the use of electrodiagnostic
techniques in the reprogramming of patients who had a
delayed suboptimal response to sacral nerve stimulation
despite having maintained a sensory response. Using surface
EMG that involved placing patch electrodes on either side
of the anal sphincter, she was able to record evoked
potentials produced by stimulation from the implantable
pulse generator (Fig. 3). She evaluated ten patients with
complaints of delayed device failure. Five of the ten were
able to be reprogrammed using electrodiagnostics. These
five patients were noted to have a more robust cMAP at an
alternate electrode and were reprogrammed to that setting
and had return of efficacy. Three patients had no cMAP
noted at any of the four electrodes and underwent revision
of the lead wire, two of whom had return of efficacy. Two
were reprogrammed to the same electrode with changes in
frequency and pulse width parameters and had improved
response. Overall, using these techniques, they were able to
restore response in 90% of patients.
More recently, alternate sites of stimulation, namely the
pudendal nerve, are being investigated. Peters et al. [5]
have compared pudendal to sacral nerve stimulation with
very promising results in the pudendal group. In determin-
ing proper lead placement, Peters utilized electrodiagnostic
techniques to confirm its placement along the nerve. Needle
electrodes were placed in the anal sphincter to measure the
cMAP produced from stimulation at the pudendal nerve.
The senior author feels it is imperative to utilize electro-
diagnostic techniques when placing the pudendal lead to
insure that it is the pudendal nerve being stimulated and
not just stimulation of the pelvic floor muscles directly.
Should pudendal placement prove to be more efficacious
and become an approved technique, the use of electro-
diagnostics may become more mainstream.
Others have used these techniques to investigate the
mechanism of action in sacral neuromodulation in both
voiding dysfunction and anal incontinence. Fowler et al.
studied a series of women with urinary retention [10]. They
measured the latency of anal sphincter contraction with
peripheral nerve stimulation of S3. The mean latency
measured was 98 ms, and she concluded the anal sphincter
contraction was due to a sensory afferent-mediated path-
way. Whether or not this was a spinal or supraspinal reflex
could not be determined. Malaguti and colleagues [11]
studied the specific action of sacral neuromodulation on the
sensory cortical areas by using somatosensory-evoked
potentials (SEPs) from the pudendal and posterior tibial
nerves in patients who were responders and non-responders
to therapy. They recorded the SEPs prior to implant (T0)
and 1 month after placement of the chronic lead in S3 at
21 Hz (T1) and at 40 Hz (T2). All patients in the group of
responders demonstrated a significant decrease in the
pudendal SEP P40 latency between T0 and T2, and
between T2 and T1 which was seen with either ipsilateral
or bilateral stimulation. This was not consistently demon-
strated with posterior tibial nerve stimulation, indicating the
specificity of pudendal sensory-evoked potentials in mea-
suring the effect of sacral neuromodulation on the cortical
sensory area via the afferent pathway. In the group of non-
responders to SNM, there was no significant difference in
latencies between T0 and T2. This finding demonstrates the
lack of a modulating effect in the cortical areas in these
patients which correlated to a lack of clinical efficacy. In
the group of responders, the difference seen between the two
frequencies indicates a possible improved response to a higher
frequency of stimulation. Based on these findings, the authors
indicate they are preferentially programming patients to these
higher rates. Their study confirmed previous observations that
SNM works via the afferent pathway at the cortical level and
further concluded that the effect was specific to the pudendal
• Implant of the lead wire (sacral and pudendal)
• Reprogramming of the IPG
• Understanding the mechanism of action of neuromodulation in the treatment of
◦ Overactive bladder (urge/frequency, urge incontinence)
◦ Urinary retention
◦ Anal incontinence
Table 2 Summary of how neu-
rodiagnostic techniques benefit
neuromodulation
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SEPs. This techniquemay also prove to be useful in predicting
those patients who will respond to therapy.
In a study of ten patients, Wyndaele et al. found that SNM
in the on vs. off mode improved the sensory thresholds within
the bladder but not in the urethra or peripheral skin. Although
this provided further evidence that SNM works via the
afferent pathways via the pelvic nerves, there was no
correlation of these findings to clinical outcomes and the
authors recommended further study [12].
Perhaps combining some of these modalities in patients
with both successful and unsuccessful responses to SNM
may provide more clinical insight as to the mechanism
of action and predict who may be a good candidate for
implant.
Although not currently approved in the United States for
the treatment of anal incontinence, SNM is approved for
this indication in Europe. Additionally, many are now
looking at treating constipation disorders with SNM.
Several studies have demonstrated the efficacy of this
therapy in treating anal incontinence, yet few have looked
at the potential mechanism of action. In a recent study by
Vitton et al., using a cat model, they were able to
demonstrate that SNM inhibited colonic activity as well as
enhanced internal anal sphincter activity. These findings
were seen with stimulation of the dorsal nerve roots,
whereas stimulation of the central end of the nerve roots
resulted in an increase in colonic activity [13]. Dinning et
al. studied the effects of SNS on patients with proven slow-
transit constipation and found that stimulation of the S3
nerve root significantly increased the pan-colonic antegrade
propagating sequence. In contrast, stimulation of the S2
nerve root resulted in a significantly increased retrograde
propagation sequence. These preliminary findings may
have an implication in choosing the most appropriate
location for stimulation based on the presenting symptom.
Conclusion
Sacral neuromodulation has gained wider acceptance and
the number of implants has risen exponentially over the
past few years. Despite the vast improvements in technique
for lead placement, tools for predicting good candidates for
therapy or optimizing the surgical outcomes have lagged
behind. The use of electrodiagnostic techniques has been
shown in small studies to have benefit in both these areas,
as well as helping to elucidate the mechanism of action
(Table 2). Additionally, these techniques may prove to be a
valuable tool in reprogramming refractory patients. As we
move on to alternate sites for implant and expand our
indications for neuromodulation, the use of electrodiagnostic
techniques may become an essential part of the procedure.
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